世界のアンチトロンビン市場2017年ー2025年:用途別(治療、研究、診断)、由来別、剤形別

◆英語タイトル:Antithrombin Market (Application - Therapeutics, Research, and Diagnostics; Source - Human, and Goat Milk; Dosage Form - Lyophilized and Liquid) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025
◆商品コード:TMR21MC056
◆発行会社(リサーチ会社):Transparency Market Research
◆発行日:2020年11月13日
◆ページ数:175
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,795 ⇒換算¥660,630見積依頼/購入/質問フォーム
Site Licence(同一拠点内共有可)USD8,795 ⇒換算¥1,002,630見積依頼/購入/質問フォーム
Enterprisewide Licence(複数拠点内共有可)USD11,795 ⇒換算¥1,344,630見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Transparency Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Transparency Market Research社の本調査資料では、世界のアンチトロンビン市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、用途別(治療、研究、診断)分析、由来別分析、剤形別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況など、以下の構成でまとめております。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・アンチトロンビンの世界市場規模:用途別(治療、研究、診断)
・アンチトロンビンの世界市場規模:由来別
・アンチトロンビンの世界市場規模:剤形別
・アンチトロンビンの世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況
【レポートの概要】

Global Antithrombin Treatment Market – Scope of Report

TMR’s report on the global antithrombin treatment market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global antithrombin treatment market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global antithrombin treatment market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global antithrombin treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global antithrombin treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global antithrombin treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global antithrombin treatment market.

The report delves into the competitive landscape of the global antithrombin treatment market. Key players operating in the global antithrombin treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global antithrombin treatment market that have been profiled in this report.

Key Questions Answered in Global Antithrombin Treatment Market Report

What is the scope of growth for product companies in the global antithrombin treatment market?
What will be the Y-o-Y growth of the global antithrombin treatment market between 2019 and 2027?
What is the influence of changing trends in technologies on the global antithrombin treatment market?
Will North America continue to be the most profitable market for antithrombin treatment providers?
Which factors are anticipated to hamper the growth of the global antithrombin treatment market during the forecast period?
Which are the leading companies in the global antithrombin treatment market?
Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global antithrombin treatment market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global antithrombin treatment market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the antithrombin treatment market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the antithrombin treatment market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global antithrombin treatment market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global antithrombin treatment more reliably and accurately.

Regional Segmentation of Antithrombin Treatment Market

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

【レポートの目次】

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Antithrombin Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Antithrombin Treatment Market Analysis and Forecasts, 2017–2027
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis Globally: Snapshot
5.3. Healthcare Industry Overview
6. Global Antithrombin Treatment Market Analysis and Forecasts, By Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Antithrombin Treatment Market Value Forecast By Application, 2017–2027
6.3.1. Therapeutic
6.3.2. Research
6.3.3. Diagnostics
6.4. Global Antithrombin Treatment Market Attractiveness By Application
7. Global Antithrombin Treatment Market Analysis and Forecasts, By Source
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Antithrombin Treatment Market Value Forecast By Source, 2017–2027
7.3.1. Human
7.3.2. Goat Milk
7.3.3. Others (Bovine, etc.)
7.4. Global Antithrombin Treatment Market Attractiveness By Source
8. Global Antithrombin Treatment Analysis and Forecasts, By Dosage Form
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Antithrombin Treatment Market Value Forecast By Dosage Form, 2017–2027
8.3.1. Lyophilized
8.3.2. Liquid
8.4. Global Antithrombin Treatment Market Attractiveness By Dosage Form
9. Global Antithrombin Treatment Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Global Antithrombin Treatment Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Antithrombin Treatment Market Attractiveness By Country/Region
10. North America Antithrombin Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Antithrombin Treatment Market Value Forecast By Application, 2017–2027
10.2.1. Therapeutic
10.2.2. Research
10.2.3. Diagnostics
10.3. North America Antithrombin Treatment Market Value Forecast By Source, 2017–2027
10.3.1. Human
10.3.2. Goat Milk
10.3.3. Others (Bovine, etc.)
10.4. North America Antithrombin Treatment Market Value Forecast By Dosage Form, 2017–2027
10.4.1. Lyophilized
10.4.2. Liquid
10.5. North America Antithrombin Treatment Market Value Forecast By Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Antithrombin Treatment Market Attractiveness Analysis
10.6.1. By Application
10.6.2. By Source
10.6.3. By Dosage Form
10.6.4. By Country
11. Europe Antithrombin Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Antithrombin Treatment Market Value Forecast By Application, 2017–2027
11.2.1. Therapeutic
11.2.2. Research
11.2.3. Diagnostics
11.3. Europe Antithrombin Treatment Market Value Forecast By Source, 2017–2027
11.3.1. Human
11.3.2. Goat Milk
11.3.3. Others (Bovine, etc.)
11.4. Europe Antithrombin Treatment Market Value Forecast By Dosage Form, 2017–2027
11.4.1. Lyophilized
11.4.2. Liquid
11.5. Europe Antithrombin Treatment Market Value Forecast By Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Antithrombin Treatment Market Attractiveness Analysis
11.6.1. By Application
11.6.2. By Source
11.6.3. By Dosage Form
11.6.4. By Country/Sub-region
12. Asia Pacific Antithrombin Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Antithrombin Treatment Market Value Forecast By Application, 2017–2027
12.2.1. Therapeutic
12.2.2. Research
12.2.3. Diagnostics
12.3. Asia Pacific Antithrombin Treatment Market Value Forecast By Source, 2017–2027
12.3.1. Human
12.3.2. Goat Milk
12.3.3. Others (Bovine, etc.)
12.4. Asia Pacific Antithrombin Treatment Market Value Forecast By Dosage Form, 2017–2027
12.4.1. Lyophilized
12.4.2. Liquid
12.5. Asia Pacific Antithrombin Treatment Market Value Forecast By Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Antithrombin Treatment Market Attractiveness Analysis
12.6.1. By Application
12.6.2. By Source
12.6.3. By Dosage Form
12.6.4. By Country/Sub-region
13. Latin America Antithrombin Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Antithrombin Treatment Market Value Forecast By Application, 2017–2027
13.2.1. Therapeutic
13.2.2. Research
13.2.3. Diagnostics
13.3. Latin America Antithrombin Treatment Market Value Forecast By Source, 2017–2027
13.3.1. Human
13.3.2. Goat Milk
13.3.3. Others (Bovine, etc.)
13.4. Latin America Antithrombin Treatment Market Value Forecast By Dosage Form, 2017–2027
13.4.1. Lyophilized
13.4.2. Liquid
13.5. Latin America Antithrombin Treatment Market Value Forecast By Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Antithrombin Treatment Market Attractiveness Analysis
13.6.1. By Application
13.6.2. By Source
13.6.3. By Dosage Form
13.6.4. By Country/Sub-region
14. Middle East & Africa Antithrombin Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Antithrombin Treatment Market Value Forecast By Application, 2017–2027
14.2.1. Therapeutic
14.2.2. Research
14.2.3. Diagnostics
14.3. Middle East & Africa Antithrombin Treatment Market Value Forecast By Source, 2017–2027
14.3.1. Human
14.3.2. Goat Milk
14.3.3. Others (Bovine, etc.)
14.4. Middle East & Africa Antithrombin Treatment Market Value Forecast By Dosage Form, 2017–2027
14.4.1. Lyophilized
14.4.2. Liquid
14.5. Middle East & Africa Antithrombin Treatment Market Value Forecast By Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Antithrombin Treatment Market Attractiveness Analysis
14.6.1. By Application
14.6.2. By Source
14.6.3. By Dosage Form
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis/Ranking By Company (2018)
15.3. Company Profiles
15.3.1. rEVO Biologics, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Growth Strategies
15.3.1.3. SWOT Analysis.
15.3.2. Grifols
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Growth Strategies
15.3.2.3. SWOT Analysis.
15.3.3. Shire plc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Growth Strategies
15.3.3.3. SWOT Analysis.
15.3.4. CSL Limited
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Growth Strategies
15.3.4.3. SWOT Analysis.
15.3.5. Kedrion S.p.A
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Growth Strategies
15.3.5.3. SWOT Analysis.
15.3.6. Octapharma AG
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Growth Strategies
15.3.6.3. SWOT Analysis.
15.3.7. Dem ilac Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Growth Strategies
15.3.7.3. SWOT Analysis.
15.3.8. Lee Bisolutions
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis.
15.3.9. Diapharma
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Growth Strategies
15.3.9.3. SWOT Analysis.
15.3.10. Scripps Laboratories, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Growth Strategies
15.3.10.3. SWOT Analysis.

List of Table

Table 01: Global Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 02: Global Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 03: Global Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 04: Global Antithrombin Market Size (US$ Mn) Forecast, by Region, 2017–2027

Table 05: North America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 06: North America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 07: North America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 08: North America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 09: Europe Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 10: Europe Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 11: Europe Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 12: Europe Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 13: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 14: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 15: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 16: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 17: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 18: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 19: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2017–2027

Table 20: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 21: Middle East & Africa Antithrombin Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 22: Middle East & Africa Size (US$ Mn) Forecast, by Source, 2017–2027

Table 23: Middle East & Africa Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2027

List of Figure

Figure 01: Global Antithrombin Market Size (US$ Mn) Forecast, 2017–2027

Figure 02: Market Value Share, by Region 2018

Figure 03: Market Value Share, by Application 2018

Figure 04: Market Value Share, by Source 2018

Figure 05: Market Value Share, by Dosage Form 2018

Figure 06: Global Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 07: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2017–2027

Figure 08: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research, 2017–2027

Figure 09: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2017–2027

Figure 10: Global Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 11: Global Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 12: Global Antithrombin Market Revenue (US$ Mn), by Human Source, 2017–2027

Figure 13: Global Antithrombin Market Revenue (US$ Mn), by Goat Milk Source, 2017–2027

Figure 14: Global Antithrombin Market Revenue (US$ Mn), by Others, 2017–2027

Figure 15: Global Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 16: Global Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 17: Global Antithrombin Market Revenue (US$ Mn), by Lyophilized Dosage Form, 2017–2027

Figure 18: Global Antithrombin Market Revenue (US$ Mn), by Liquid Dosage Form, 2017–2027

Figure 19: Global Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 20: Global Antithrombin Market Value Share Analysis, by Region, 2018 and 2027

Figure 21: Global Antithrombin Market Attractiveness Analysis, by Region, 2017–2027

Figure 22: North America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 23: North America Antithrombin Market Attractiveness Analysis, by Country, 2019–2027

Figure 24: North America Antithrombin Market Value Share Analysis, by Country, 2018 and 2027

Figure 25: North America Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 26: North America Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 27: North America Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 28: North America Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 29: North America Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 30:North America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 31: Europe Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 32: Europe Antithrombin Market Attractiveness Analysis, by Country, 2019–2027

Figure 33: Europe Antithrombin Market Value Share Analysis, by Country, 2018 and 2027

Figure 34: Europe Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 35: Europe Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 36: Europe Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 37: Europe Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 38: Europe Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 39: Europe Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 40: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 41: Asia Pacific Antithrombin Market Attractiveness Analysis, by Country, 2019–2027

Figure 42: Asia Pacific Antithrombin Market Value Share Analysis, by Country, 2018 and 2027

Figure 43: Asia Pacific Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 44: Asia Pacific Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 45: Asia Pacific Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 46: Asia Pacific Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 47: Asia Pacific Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 48:Asia Pacific Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 49: Latin America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 50: Latin America Antithrombin Market Attractiveness Analysis, by Country, 2019–2027

Figure 51: Latin America Antithrombin Market Value Share Analysis, by Country, 2018 and 2027

Figure 52: Latin America Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 53: Latin America Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 54: Latin America Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 55: Latin America Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 56: Latin America Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 57: Latin America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 58: Middle East & Africa Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 59: Middle East & Africa Antithrombin Market Value Share Analysis, by Application, 2018 and 2027

Figure 60: Middle East & Africa Antithrombin Market Value Share Analysis, by Source, 2018 and 2027

Figure 61: Rest of the World Antithrombin Market Value Share Analysis, by Dosage Form, 2018 and 2027

Figure 62: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Application, 2019–2027

Figure 63: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Source, 2019–2027

Figure 64: Middle East & Africa Antithrombin Market Attractiveness Analysis, by Dosage Form, 2019–2027

Figure 65: Heat Map Analysis By Company 2018

Figure 66: Revenue for the LFB Group (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 67: Breakdown of Net Sales, by Business Segment, 2018

Figure 68: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 69: Breakdown of Net Sales, by Business Segment, 2018

Figure 70: Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2018

Figure 71: Breakdown of Net Sales, by Region, 2018

Figure 72: CSL Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 73: Breakdown of Net Sales by Business segments, 2018

Figure 74: Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のアンチトロンビン市場2017年ー2025年:用途別(治療、研究、診断)、由来別、剤形別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆